U.K. regulatory agency reinforces its commitment to safe, high-quality, and risk-mitigated clinical trials in the country.

Market pressures have lead to strategic shifts globally with the latest challenge being tariff pressures.

Expansion and market access success resulted in major gains with customer expectations still unmet.

Companies commitments to sustainable development continue to be a trend re-energized with AI opportunities.

Coming Soon

Coming Soon